• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥漫性侵袭性非霍奇金淋巴瘤中根据形态学标准判断免疫表型的可预测性

Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin's lymphomas.

作者信息

Jaffe E S, Strauchen J A, Berard C W

出版信息

Am J Clin Pathol. 1982 Jan;77(1):46-9. doi: 10.1093/ajcp/77.1.46.

DOI:10.1093/ajcp/77.1.46
PMID:7055097
Abstract

Diffuse aggressive non-Hodgkin's lymphomas are immunologically and morphologically heterogeneous. Morphologic subclassifications have been proposed with a presumptive relationship to immunologic phenotype. Six histologic types were studied, four of presumed follicular origin (large cleaved, large non-cleaved, mixed follicular center cell, and blastic) and two of presumed nonfollicular origin (pleomorphic pyroninophilic and pleomorphic convoluted). Two of these follicular subtypes were found to be associated with the frequent presence of B-cell markers; large non-cleaved, six of seven; and blastic, four of six. However, four of nine T-cell lymphomas were misclassified as lesions of follicular center cell type, indicating the difficulty of distinguishing some convoluted cells of T-cell lymphoma from irregularly cleaved cells of follicular lymphoma. Pleomorphic pyroninophilic or B-immunoblastic morphology was associated with B-cell markers in only two of six cases; two additional cases had T-cell markers, one had histiocytic markers and in one case, no markers were demonstrable. Thus, this morphology may reflect a common pathway of transformed lymphoid cells. Some cases of T-cell origin could be recognized by the striking pleomorphic convoluted histology (three of five cases) but morphologic overlap with pleomorphic B-cell tumors, particularly transformed nodular lymphomas, posed a problem. This histopathologic subclassification correctly predicted immunologic phenotype in only 61% of cases, suggesting that in diffuse non-Hodgkin's lymphomas, histologic appearance alone may not be a reliable indicator of immunologic surface markers.

摘要

弥漫性侵袭性非霍奇金淋巴瘤在免疫和形态学上具有异质性。已提出形态学亚分类,并假定其与免疫表型有关。研究了六种组织学类型,其中四种假定起源于滤泡(大裂细胞型、大无裂细胞型、混合滤泡中心细胞型和母细胞型),两种假定起源于非滤泡(多形性嗜派洛宁细胞型和多形性卷曲细胞型)。发现其中两种滤泡亚型经常出现B细胞标志物;大无裂细胞型,7例中有6例;母细胞型,6例中有4例。然而,9例T细胞淋巴瘤中有4例被错误分类为滤泡中心细胞型病变,这表明区分T细胞淋巴瘤的一些卷曲细胞与滤泡淋巴瘤的不规则裂细胞存在困难。多形性嗜派洛宁细胞型或B免疫母细胞形态仅在6例中的2例中与B细胞标志物相关;另外2例有T细胞标志物,1例有组织细胞标志物,1例未显示标志物。因此,这种形态可能反映了转化淋巴细胞的共同途径。一些T细胞起源的病例可通过显著的多形性卷曲组织学特征识别(5例中有3例),但与多形性B细胞肿瘤,特别是转化的结节性淋巴瘤的形态学重叠构成了一个问题。这种组织病理学亚分类仅在61%的病例中正确预测了免疫表型,这表明在弥漫性非霍奇金淋巴瘤中,仅组织学表现可能不是免疫表面标志物的可靠指标。

相似文献

1
Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin's lymphomas.弥漫性侵袭性非霍奇金淋巴瘤中根据形态学标准判断免疫表型的可预测性
Am J Clin Pathol. 1982 Jan;77(1):46-9. doi: 10.1093/ajcp/77.1.46.
2
Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.使用多种细胞标志物对非霍奇金淋巴瘤进行特征描述。对72例病例的免疫、形态学和细胞化学研究。
Am J Pathol. 1979 Feb;94(2):349-80.
3
Immunologic phenotypes of diffuse, aggressive, non-Hodgkin's lymphomas. Correlation with clinical features.弥漫性侵袭性非霍奇金淋巴瘤的免疫表型。与临床特征的相关性。
Cancer. 1984 Oct 1;54(7):1310-7. doi: 10.1002/1097-0142(19841001)54:7<1310::aid-cncr2820540714>3.0.co;2-9.
4
Non-Hodgkin's lymphomas: an ultrastructural study correlating morphology with immunologic cell type.非霍奇金淋巴瘤:一项将形态学与免疫细胞类型相关联的超微结构研究。
Cancer. 1979 Aug;44(2):504-28. doi: 10.1002/1097-0142(197908)44:2<504::aid-cncr2820440221>3.0.co;2-h.
5
An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute.非霍奇金淋巴瘤组织学进展的尸检研究。来自美国国立癌症研究所的192例病例。
Cancer. 1983 Aug 1;52(3):393-8. doi: 10.1002/1097-0142(19830801)52:3<393::aid-cncr2820520302>3.0.co;2-m.
6
Predictability of immunologic phenotype of malignant lymphomas by conventional morphology: a study of 60 cases.通过传统形态学预测恶性淋巴瘤免疫表型:60例研究。
Cancer. 1979 Apr;43(4):1216-24. doi: 10.1002/1097-0142(197904)43:4<1216::aid-cncr2820430409>3.0.co;2-f.
7
Malignant lymphoma in Hawaii-Japanese: a retrospective morphologic survey.夏威夷日裔人群中的恶性淋巴瘤:一项回顾性形态学调查。
Hematol Oncol. 1989 May-Jun;7(3):219-32. doi: 10.1002/hon.2900070305.
8
Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.非霍奇金淋巴瘤细胞的表面标志物及功能特性与组织学的关系
Cancer. 1978 Oct;42(4):1804-17. doi: 10.1002/1097-0142(197810)42:4<1804::aid-cncr2820420419>3.0.co;2-l.
9
Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.157例非霍奇金淋巴瘤患者的表面表型、组织学及性质
Br J Cancer. 1979 Jul;40(1):11-34. doi: 10.1038/bjc.1979.137.
10
Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.非霍奇金淋巴瘤中的免疫和细胞化学细胞标志物。
Lab Invest. 1976 Nov;35(5):430-8.

引用本文的文献

1
Immunohistochemistry effect on diagnostic reliability for paediatric cancer at Mwanza region, Tanzania: a laboratory descriptive study.坦桑尼亚姆万扎地区免疫组织化学对儿童癌症诊断可靠性的影响:一项实验室描述性研究
Ecancermedicalscience. 2024 Dec 5;18:1809. doi: 10.3332/ecancer.2024.1809. eCollection 2024.
2
The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases.非霍奇金淋巴瘤中肿瘤生长的生物学特性。220例病例的双参数流式细胞术研究。
J Clin Invest. 1984 Apr;73(4):1201-14. doi: 10.1172/JCI111306.
3
Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.
淋巴增生性疾病的免疫组织学细胞表型。对564例病例进行综合评估,其中包括257例根据国际工作分类法分类的非霍奇金淋巴瘤。
Am J Pathol. 1983 Nov;113(2):207-21.
4
Cytodiagnosis of non-Hodgkin's lymphoma. A morphological analysis of 215 biopsy proven cases.
Virchows Arch A Pathol Anat Histopathol. 1984;403(3):213-33. doi: 10.1007/BF00694898.
5
Current views on the diagnosis of lymphomas by surface and cytoplasmic markers.目前关于通过表面和细胞质标志物诊断淋巴瘤的观点。
Surv Immunol Res. 1982;1(2):162-72. doi: 10.1007/BF02918342.
6
EBM/11 reactivity in malignant histiocytosis.恶性组织细胞增多症中的EBM/11反应性
J Clin Pathol. 1988 Dec;41(12):1305-9. doi: 10.1136/jcp.41.12.1305.
7
Application of quantifiable criteria in the Lukes and Collins classification of non-Hodgkin's lymphomas.可量化标准在非霍奇金淋巴瘤的卢克斯和柯林斯分类中的应用。
Virchows Arch A Pathol Anat Histopathol. 1987;411(6):575-81. doi: 10.1007/BF00713289.
8
SIg-E- ("null-cell") non-Hodgkin's lymphomas. Multiparametric determination of their B- or T-cell lineage.SIg-E-(“无标记细胞”)非霍奇金淋巴瘤。其B细胞或T细胞谱系的多参数测定。
Am J Pathol. 1985 Sep;120(3):356-70.
9
Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia.T细胞肿瘤的免疫表型和抗原受体基因重排分析
Am J Pathol. 1989 Apr;134(4):761-85.
10
Clonality of T cell and phenotypically undefined lymphoid neoplasms: the value of genotypic analyses.T细胞及表型未明确的淋巴样肿瘤的克隆性:基因分型分析的价值
J Clin Pathol. 1990 Jul;43(7):548-53. doi: 10.1136/jcp.43.7.548.